ZIMURA in Combination With Eylea in Patients With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)

首次发布于 2017 年 12 月 15 日

Eylea to Treat Retinal Pigment Epithelial Detachment (RPED) Secondary to Wet Age-Related Macular Degeneration (wAMD)

计划入组 37 人 · 首次发布于 2014 年 5 月 20 日

Ozurdex in Suboptimal Diabetic Macular Edema Patients

计划入组 200 人 · 首次发布于 2021 年 4 月 23 日

Aflibercept(Eylea, Zaltrap, Yesafili, Eydenzelt, Ahzantive, Afqlir, Baiama, Opuviz, Pavblu, Mynzepli, Vgenfli, Eiyzey)

Rx

Eylea Biosimilar(Alteogen, Inc.)

Aflibercept/Rinucumab

LABORATORIO ELEA PHOENIX S.A.

Argentina

Vabysmo Shows Superior CST Reduction Compared to Eylea HD in DME and nAMD: Meta-Analysis

Regeneron Navigates EYLEA Decline with Pipeline Diversification and Regulatory Wins

FDA Approves Pavblu, Fifth Biosimilar to Eylea, for Retinal Conditions